RAPT Therapeutics, Inc.

Historical 13F Holders

Symbol
RAPT
CUSIP
75382E109
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 75382E109 since 12/18/2024, largest first.

Filer % of Class Filed
Medicxi IV LP 13G
16.9% 1/6/2025
Event 12/27/2024
TCG Crossover GP II, LLC 13G
10.0% 1/3/2025
Event 12/27/2024
Redmile Group, LLC 13G/A
9.9% 2/14/2025
Event 12/31/2024
Foresite Capital Fund VI LP 13G
9.3% 12/30/2024
Event 12/23/2024
Vanguard Group Inc 13G 6.3% 4/30/2025
Event 3/31/2025
Glazer Capital, LLC 13G
5.4% 2/9/2026
Event 2/2/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
Deep Track Capital, LP 13G
Amended under CUSIP 75382E208 on 2/13/2026
9.9% 12/23/2024
Event 12/23/2024
RTW Investments, LP 13G
Amended under CUSIP 75382E208 on 5/15/2026
8.9% 5/15/2025
Event 3/31/2025
Column Group II, LP 13D/A
4.9% 12/23/2024
Event 12/23/2024
Perceptive Advisors LLC 13G/A
4.5% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G/A 1.7% 4/25/2025
Event 3/31/2025
FMR LLC 13G/A
0.4% 2/7/2025
Event 1/31/2025
Biotechnology Value Fund L P 13G/A
0% 11/14/2025
Event 9/30/2025
Orbimed Advisors LLC 13G/A 0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q4 3 2.96 M $100M
2025 Q3 3 2.97 M $76.7M
2025 Q2 2 1.34 M $10.7M
2025 Q1 93 131 M $160M
2024 Q4 95 127 M $199M
2024 Q3 96 29.8 M $59.9M
2024 Q2 110 31.8 M $97.0M
2024 Q1 129 32.0 M $287M
2023 Q4 113 35.0 M $869M
2023 Q3 99 34.8 M $578M
2023 Q2 100 34.1 M $637M
2023 Q1 107 33.3 M $611M
2022 Q4 97 32.1 M $636M
2022 Q3 99 30.0 M $721M
2022 Q2 88 29.7 M $543M
2022 Q1 86 28.0 M $616M
2021 Q4 103 27.8 M $1.02B
2021 Q3 111 26.4 M $818M
2021 Q2 116 26.7 M $847M
2021 Q1 83 21.1 M $468M
2020 Q4 84 20.4 M $404M
2020 Q3 69 16.8 M $542M
2020 Q2 55 15.0 M $443M
2020 Q1 39 11.7 M $248M
2019 Q4 28 9.14 M $252M